Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Severe hypoglycemic events have been associated with increased cardiovascular mortality in patients with diabetes, which may be explained by hypoglycemia-induced inflammation. We used ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during hyperinsulinemic-euglycemic (5.0 mmol/L)-hypoglycemic (2.6 mmol/L) clamps in 11 healthy participants, 10 patients with type 1 diabetes and normal awareness of hypoglycemia (NAH), and 10 patients with type 1 diabetes and impaired awareness (IAH) to test whether the composition and inflammatory function of immune cells adapt to a more proinflammatory state after hypoglycemia. Hypoglycemia increased leukocyte numbers in healthy control participants and patients with NAH but not in patients with IAH. Leukocytosis strongly correlated with the adrenaline response to hypoglycemia. Ex vivo, PBMCs and monocytes displayed a more robust cytokine response to microbial stimulation after hypoglycemia compared with euglycemia, although it was less pronounced in patients with IAH. Of note, hypoglycemia increased the expression of markers of demargination and inflammation in PBMCs. We conclude that hypoglycemia promotes mobilization of specific leukocyte subsets from the marginal pool and induces proinflammatory functional changes in immune cells. Inflammatory responses were less pronounced in IAH, indicating that counterregulatory hormone responses are key modulators of hypoglycemia-induced proinflammatory effects. Hypoglycemia-induced proinflammatory changes may promote a sustained inflammatory state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315 · cited 1×
“For instance, a highly active glycolytic metabolism has been shown to drive proinflammatory cytokine production in M1 macrophages and is important for activated effector T cells (31).”
BackgroundSevere hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Wong, K. L., Tai, J. J.-Y., Wong, W.-C., Han, H., Sem, X., Yeap, W.-H., Kourilsky, P., & Wong, S.-C. (2011) · Blood · doi:10.1182/blood-2010-12-326355 · Cited by 1,101
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651 · cited 1×
“Hypoglycemia awareness state, initially assessed by a Dutch version of the Cox questionnaire in which a score of 0–1 of 5 indicates normal awareness and a score $ 3 indicates impaired awareness (24,25), was determined on the basis of adrenaline and symptomatic responses to hypoglycemic clamp.”
MethodDagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471 · cited 1×
“Patients with impaired awareness of hypoglycemia (IAH) are at particularly high risk of hypoglycemia (21) because they lack hypoglycemia warning symptoms and have attenuated adrenaline responses (1,22).”
BackgroundAssociation between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433 · cited 2×
“Patients with impaired awareness of hypoglycemia (IAH) are at particularly high risk of hypoglycemia (21) because they lack hypoglycemia warning symptoms and have attenuated adrenaline responses (1,22).”
BackgroundPrevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes
Geddes, J., Schopman, J. E., Zammitt, N. N., & Frier, B. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02413.x · Cited by 387 · cited 1×
“Patients with impaired awareness of hypoglycemia (IAH) are at particularly high risk of hypoglycemia (21) because they lack hypoglycemia warning symptoms and have attenuated adrenaline responses (1,22).”
Background
Cited by
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
“The production of proinflammatory cytokines from stimulated polymorphonuclear cells and monocytes was larger after hypoglycemia compared to euglycemia, although it was less prominent in patients with IAH [184].”
BackgroundAmiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Abraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
“hypoglycemic episodes in patients with good glycemic control are associated with increased inflammatory markers(77) and these proinflammatory changes may promote a sustained inflammatory state.(78)”
Sun, B., Luo, Z., & Zhou, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01200-7 · Cited by 168
Glycemic variability in the development of cardiovascular complications in diabetes
Nusca, A., Tuccinardi, D., Albano, M., Cavallaro, C., Ricottini, E., Manfrini, S., Pozzilli, P., & Di Sciascio, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3047 · Cited by 158
Dowey, R., Iqbal, A., Heller, S. R., Sabroe, I., & Prince, L. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678771 · Cited by 162
Glucose Variability: How Does It Work?
Klimontov, V. V., Saik, O., & Korbut, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157783 · Cited by 142
“Nonetheless, in patients with the T1D, the J-index, a GV parameter, correlated negatively with CD34+ EPC count [77].”
BackgroundInfluentialGarcía-Rodríguez, D., & Giménez-Cassina, A. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.732120 · Cited by 137
“Interestingly, sustained hypoglycemia has been associated with increased inflammatory states (Ratter et al., 2017).”
BackgroundKahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 122
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
Iqbal, A., Prince, L. R., Novodvorský, P., Bernjak, A., Thomas, M. R., Birch, L., Lambert, D., Kay, L. J., Wright, F., Macdonald, I. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01168 · Cited by 97
Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
Christou, M., Christou, P. A., Kyriakopoulos, C., Christou, G. A., & Tigas, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119357 · Cited by 71
Al‐Rashed, F., Sindhu, S. T. A. K., Arefanian, H., Madhoun, A. S. A., Kochumon, S., Thomas, R., Al-Kandari, S., Alghaith, A., JACOB, T. K., Al‐Mulla, F., et al. (2020) · Cells · doi:10.3390/cells9081892 · Cited by 67
“Notably, both hyperglycemia [33,34] and hypoglycemia [35,36] have been implicated in the progression of T2D-associated pathologies.”
BackgroundPathogen manipulation of host metabolism: A common strategy for immune evasion
Freyberg, Z., & Harvill, E. T. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006669 · Cited by 63
Guan, S., Shen, Y., Ge, H., Xiong, W., He, L., Liu, L., Yin, C., Wei, X., & Gao, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00770 · Cited by 64
Zhao, F. L., Deng, J., Xu, X., Cao, F., Lu, K., Li, D., Cheng, X., Wang, X., & Zhao, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1203-8 · Cited by 59
Yamamoto, H., Yoshida, N., Shinke, T., Otake, H., Kuroda, M., Sakaguchi, K., Hirota, Y., Toba, T., Takahashi, H., Terashita, D., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.010 · Cited by 46
Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses
Winkler, Z., Kuti, D., Polyák, Á., Juhász, B., Gulyás, K., Lénárt, N., Dénes, Á., Ferenczi, S., & Kovács, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42728-3 · Cited by 46
Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
Xiao, Y., Yang, H., Lu, J., Li, D., Xu, C., & Risch, H. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6250-8 · Cited by 44
de Galan, B. E., McCrimmon, R. J., Ibberson, M. R., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14240 · Cited by 44
Self-citationYoshida, N., Yamamoto, H., Shinke, T., Otake, H., Kuroda, M., Terashita, D., Takahashi, H., Sakaguchi, K., Hirota, Y., Emoto, T., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0577-8 · Cited by 38
Verhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen‐Bjergaard, U., & de Galan, B. E. (2022) · Diabetes · doi:10.2337/db22-0246 · Cited by 37
Self-citationHeller, S. R., Geybels, M. S., Iqbal, A., Liu, L., Wagner, L., & Chow, E. (2021) · Diabetologia · doi:10.1007/s00125-021-05556-7 · Cited by 37
Platelet function following induced hypoglycaemia in type 2 diabetes
Kahal, H., Aburima, A. A., Spurgeon, B. E. J., Wraith, K. S., Rigby, A. S., Sathyapalan, T., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.004 · Cited by 34
“[31] Ratter JM, Rooijackers HM, Tack CJ, Hijmans AG, Netea MG, de Galan BE, et al.”
BackgroundThe early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
Jenkins, A. J., Januszewski, A. S., & O'Neal, D. N. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000169 · Cited by 36
Furr, M. O., & McKenzie, H. C. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15923 · Cited by 30
Wei, W., Zhao, S., Fu, S.-L., Lan, Y., Mao, H., Tan, Q., Xu, P., & Yang, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00536 · Cited by 32
Animal-Free Human Whole Blood Sepsis Model to Study Changes in Innate Immunity
Messerer, D. A. C., Vidoni, L., Erber, M., Stratmann, A. E. P., Bauer, J. M., Braun, C., Hug, S., Adler, A., Ekdahl, K. N., Nilsson, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571992 · Cited by 29
“Also, hypoglycemia has been shown to aggravate the response to inflammatory stimuli, including LPS (36).”
BackgroundKlimontov, V. V., Mavlianova, K. R., Орлов, Н. Б., Semenova, J. F., & Korbut, A. I. (2023) · Biomedicines · doi:10.3390/biomedicines11102843 · Cited by 28
“In healthy individuals and those with T1D, hypoglycemia promotes leukocyte mobilization into the bloodstream and induces proinflammatory changes in these cells [60].”
BackgroundLi, S., Tang, X., Luo, Y., Wu, B., Huang, Z., Li, Z., Peng, L., Ling, Y., Zhu, J., Zhong, J., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01126-0 · Cited by 27
Ratter, J. M., van Heck, J. I. P., Rooijackers, H. M. M., Jansen, H. J., van Poppel, P. C. M., Tack, C. J., & Stienstra, R. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0120-019rr · Cited by 27
Self-citationEnvironmental Signals Influencing Myeloid Cell Metabolism and Function in Diabetes
Ratter, J. M., Tack, C. J., Netea, M. G., & Stienstra, R. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.04.008 · Cited by 28
Self-citationHsu, J., Yang, Y., Chuang, S.-L., Huang, K., Lee, J., & Lin, L. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.025438 · Cited by 27
“29,30 Collectively, high GV increases the risks associated with both hyperglycemia and hypoglycemia, subsequently inducing oxidative stress, inflammatory cytokine production, epigenetic changes, endothelial dysfunction, and β - cell dysfunction, more than sustained chronic hyperglycemia.”
Li, G., Zhong, S., Wang, X., & Zhuge, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1222409 · Cited by 26
Fang, Q., Shi, J., Zhang, J. Y., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01884-7 · Cited by 23
Komorowska, J., Wątroba, M., Bednarzak, M., Grabowska, A. D., & Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063110 · Cited by 24
“Neuroinflammatory processes can be particularly difficult to predict in diabetes because the cytokine profile in the CNS depends on serum glucose concentration [10].”
BackgroundEyileten, C., Wicik, Z., Keshwani, D., Aziz, F., Aberer, F., Pferschy, P. N., Tripolt, N. J., Sourij, C., Prietl, B., Prüller, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01517-5 · Cited by 21
Carvalho, R. C., Nishi, F. A., Ribeiro, T. B., França, G. G., & Aguiar, P. M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200130093523 · Cited by 20
Abdelhamid, Y. A., Bernjak, A., Phillips, L. K., Summers, M. J., Weinel, L. M., Lange, K. M., Chow, E., Kar, P., Horowitz, M., Heller, S. R., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004810 · Cited by 19
Dysglycemia in Children with Severe Acute Malnutrition: A Systematic Review and Meta-Analysis
Ledger, E., Harawa, P. P., Daniel, A. I., Candler, T. P., Prentice, A. M., & Bandsma, R. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa138 · Cited by 21
“Hypoglycemia has been found to have proinflammatory and prothrombotic effects and is associated with an increased risk of cardiovascular events (8).”
BackgroundThe effect of insulin-induced hypoglycemia on inflammatory markers: a systematic review
Drummond, J. B., Barbosa, I. G., Dantzer, R., & Teixeira, A. L. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.003 · Cited by 16
Manosroi, W., Phimphilai, M., Waisayanand, N., Buranapin, S., Deerochanawong, C., Gunaparn, S., Phrommintikul, A., Wongcharoen, W., & for the CORE‐Thailand investigators (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14073 · Cited by 16
“…is that long-term glucose variability heightens the risk of hypoglycemia, which has been found to be the main cause of the deleterious effect on cardiovascular function through the release of in fl ammatory cytokines and pro-atherothrombotic release plaques plus platelet activation 27,28 .”
BackgroundMellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06225-1 · Cited by 16
“These responses are observed in individuals regardless of their diabetes status, level of prior glucose control or awareness of hypoglycaemia [48–50], and can persist up to 7 days post-hypoglycaemia [47, 48].”
BackgroundRatter, J. M., Rooijackers, H. M. M., Jacobs, C. W. M., de Galan, B. E., Tack, C. J., & Stienstra, R. (2018) · Diabetologia · doi:10.1007/s00125-018-4683-2 · Cited by 16
Self-citationNutrients and Immunometabolism: Role of Macrophage NLRP3
Larson, K., Alvine, T., Wu, D., Kalupahana, N. S., Moustaïd‐Moussa, N., & Roemmich, J. N. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa085 · Cited by 17
Verhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen‐Bjergaard, U., & de Galan, B. E. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15205 · Cited by 14
Self-citationEeg‐Olofsson, K., Nathanson, D., Spelman, T. D., Kyhlstedt, M., Seibold, A., Levrat‐Guillen, F., & Bolinder, J. (2025) · Diabetologia · doi:10.1007/s00125-025-06438-y · Cited by 12
“Studies in healthy individuals and in people with type 1 diabetes indicate that acute hypoglycaemia leads to increased proinflammatory cytokines, mobilisation of inflammatory leukocytes and increased platelet reactivity [16–18].”
Wu, I., Hsu, C., Chen, C., Chuang, S., Cheng, C.-W., Hsieh, W.-S., Wu, M., Liu, Y., Liu, Y.-H., Tsai, T.-L., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly147 · Cited by 11
Fährmann, E. R., ADKINS, L. J., & Driscoll, H. K. (2021) · Diabetes Care · doi:10.2337/dc20-2757 · Cited by 10
Nam, S., Jeon, S., Ash, G. I., WEINZIMER, S. A., Dunton, G. F., Parekh, N., Grey, M. J., Chen, K., Lee, M., Sajdlowska, A., et al. (2024) · Research in Nursing & Health · doi:10.1002/nur.22420 · Cited by 9
Thyroid Hormone T4 Alleviates Traumatic Brain Injury by Enhancing Blood–Brain Barrier Integrity
Khandelwal, M., Ying, Z., & Gómez‐Pinilla, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199632 · Cited by 11
“Studies have shown that in hypoglycemic conditions, the end-feet pool of AQP4 changes along with degraded tight junction proteins leading to an edematous environment in the brain, neuronal injury, and inflammation [54–56].”
Mathematical modeling of energy consumption in the acute inflammatory response
Ramirez-Zuniga, I., Rubin, J. E., Swigon, D., & Clermont, G. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.08.033 · Cited by 9
Drummond, J., Soares, B. S., Vieira, É. L. M., Pedrosa, W., Teixeira, A. L., & Ribeiro‐Oliveira, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577446 · Cited by 10
Ali, N., Janssen, A. W. M., Jaeger, M., de Wijer, L. V., van der Heijden, W., ter Horst, R., Vart, P., van Gool, A. J., Joosten, L. A. B., Netea, M. G., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14172 · Cited by 9
Self-citationAnfinogenova, Y., Grakova, E. V., Shvedova, M., Kopeva, K. V., Teplyakov, A. T., & Popov, S. V. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9647-y · Cited by 8
Law, T. Y., Moeller, E. A., Hubbard, Z., Rosas, S., Andreoni, A. R., & Chim, H. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.06.068 · Cited by 8
Ravi, P. S., & Babu, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11246-z · Cited by 6
Liu, X., Yang, X., & Wu, N. (2024) · Journal of Diabetes Research · doi:10.1155/2024/9958586 · Cited by 6
Padilla, L., Argüero‐Sánchez, R., Rodríguez‐Trejo, J. M., Carranza‐Castro, P. H., Suárez‐Cuenca, J. A., Polaco‐Castillo, J., Silvio, M. D., López‐Gutiérrez, J., Olguín, H., Hernández‐Patricio, A., et al. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3024 · Cited by 5
A data-driven model of the role of energy in sepsis
Ramirez-Zuniga, I., Rubin, J. E., Swigon, D., Redl, H. R., & Clermont, G. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110948 · Cited by 5
Myśliwiec, M., Czupryniak, L., Gellert, R., Jankowski, P., Mastalerz–Migas, A., Rękas, M., Strojek, K., & Walczak, M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01769-w · Cited by 4
“…on processes that are implicated in development of CVD. Studies in healthy indi‑ viduals and in those with diabetes, particularly T1D, indicate that acute hypoglycemia leads to increased proinflammatory cytokines, mobiliza‑ tion of inflammatory leukocytes, and increased platelet reactivity [14–16].”
Lin, C., Li, C., Liu, C.-S., Lin, C., Yang, S.-Y., & Li, T. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02243-y · Cited by 6
“…and adverse outcomes associated with glucose variation include oxidative stress [18–22]; epigenetics changes [23, 24]; platelet activation and inflammatory cytokines [25, 26]; and endothelial dysfunction and damage [27], which share the same biological process for damage associated with IMT [28].”
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients
Bonaventura, A., Gallo, F., Carbone, F., Sacchi, G., Liberale, L., Dallegri, F., Maggi, D. C., Montecucco, F., & Cordera, R. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.008 · Cited by 4
Hiding in plain sight? A review of post-convulsive leukocyte elevations
Vega, J. L., Komisaruk, B. R., & Stewart, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1021042 · Cited by 4
Iqbal, A., Storey, R. F., & Ajjan, R. (2022) · Diabetes · doi:10.2337/dbi22-0028 · Cited by 4
“Hypoglycemia-primed monocytes demonstrated a trend toward augmented proinflammatory cytokine production after in vitro simulation, in agreement with hypoglycemic priming of innate immune cells (11,13).”
BackgroundSampedro, F., Stantonyonge, N., Martínez‐Horta, S., Nan, M. N., Camacho, V., & Chico, A. I. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12910 · Cited by 5
Koshizaka, M., Ishibashi, R., Maeda, Y., Ishikawa, T., Maezawa, Y., Takemoto, M., & Yokote, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00587-w · Cited by 3
“Furthermore, hypoglycemia decreases the immune response and induces a proinflammatory state [13].”
BackgroundVerhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen‐Bjergaard, U., & de Galan, B. E. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02095-w · Cited by 3
“Adrenaline may be involved in the inflammatory responses to hypoglycaemia and one study reported reduced inflammatory responses in people with diabetes and attenuated adrenaline responses to hypoglycaemia [4].”
BackgroundInfluentialSelf-citationTian, L., Liu, K., Li, L., Wu, W., & Zhang, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26137 · Cited by 2
Ashebir, Y. G., Godie, Y., Tadesse, A., Mihretu, E., & Birhanu, D. (2024) · Journal of Advanced Pediatrics and Child Health · doi:10.29328/journal.japch.1001066 · Cited by 2
Preoperative Hypoglycemia Increases Infection Risk After Trigger Finger Injection and Release
Buchanan, P. J., Law, T. Y., Rosas, S., Hubbard, Z., Mast, B. A., & Chim, H. (2018) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001667 · Cited by 3
Souto, L. R. M. (2020) · Aesthetic Plastic Surgery · doi:10.1007/s00266-020-01974-x · Cited by 1
Ajie, M., van Heck, J. I. P., Verhulst, C. E. M., Fabricius, T. W., Hendriksz, M. S., McCrimmon, R. J., Pedersen‐Bjergaard, U., de Galan, B. E., Stienstra, R., & Tack, C. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15712 · Cited by 1
Self-citationKhavrona, O. P., Biletska, L. P., & Kliushta, M. Y. (2025) · Art of Medicine · doi:10.21802/artm.2025.2.34.86 · Cited by 1
Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia
Mustafajev, I. F., Hendriksz, M. S., Stienstra, R., Tack, C. J., de Galan, B. E., & Meijer, R. I. (2026) · Diabetologia · doi:10.1007/s00125-026-06667-9 · Cited by 1
“In the hyperinsuli-naemic–hypoglycaemic clamp studies that our group has performed, we observed a consistent positive correlation between the adrenaline response to hypoglycaemia and the increase in granulocyte, lymphocyte and monocyte counts [8, 15].”
Self-citationAkute diabetische Stoffwechselentgleisungen
Mertens, M., Dauben, L., Roden, M., & Müssig, K. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1270-8878 · Cited by 1
“Zusätzlich werden bei Hypoglykämien proinflammatorische Zytokine wie Tumornekrosefaktor-alpha (TNF-α) und die Interleukine (IL-6, IL-8 und IL-1β) ausgeschüttet [11], die ebenso wie die Insulin-antagonistischen Hormone Kortisol, Wachstumshormon sowie Adrenalin und Noradrenalin zu einer peripheren Insulinresistenz führe…”
Daily Low Dose of Erythropoietin in Neuroinflammation; EPO Might Be Hazardous in COVID-19Preprint
Nejat, R., Sadr, A. S., Ebrahimi, A., Nabati, A., & Eshaghi, E. (2020) · Preprints.org · doi:10.20944/preprints202006.0107.v2 · Cited by 1
“[2, 3] This phenomenon, with its energy-consuming metabolic-demanding nature has been linked to the secondary pathological changes elicited in hypoglycemia [4], the ischemic brain disorders [5, 6], intracerebral hemorrhage [7, 8], traumatic brain injury (TBI) [9, 10], Alzheimer’s disease [1113], Parkinson’s disease [1…”
BackgroundHaas, A. V., Koefoed, A. W., Celli, J., Bonyhay, I., White, J., Meyer, K. M., Easly-Merski, R. M., Heydarpour, M., Adler, G. K., & Freeman, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae919
Metabolomic profiling of acute diabetes complications in children with type 1 diabetes mellitus
Małachowska, B., & Fendler, W. M. (2020) · Postępy Polskiej Medycyny i Farmacji · doi:10.5604/01.3001.0014.1586
Daily Low Dose of Erythropoietin and NeuroinflammationPreprint
Nejat, R., Sadr, A. S., Ebrahimi, A., Nabati, A., & Eshaghi, E. (2020) · Preprints.org · doi:10.20944/preprints202006.0107.v1
“demanding nature has been linked to the secondary pathological changes elicited in hypoglycemia [7], the ischemic brain disorders [8, 9], intracerebral hemorrhage [10, 11], traumatic brain injury (TBI) [12, 13], Alzheimer’s disease [14-16], Parkinson’s disease [17, 18] and other neurodegenerative disorders such as amy…”
BackgroundMertens, M., Dauben, L., Roden, M., & Müssig, K. (2021) · Diabetes aktuell · doi:10.1055/a-1645-9436
Dzhun, Y. Y., Marushko, Y. Y., Saienko, Y. A., Rudenko, N. M., & Mankovsky, B. (2022) · Ukrainian journal of cardiovascular surgery · doi:10.30702/ujcvs/22.30(03)/dm031-3543
Iqbal, A., Chow, E., Jones, T. W., & Heller, S. R. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch40
Intermittierende Glukoseüberwachung: Einfluss auf kardiovaskuläre Komplikationen
Müssig, K. (2025) · Info Diabetologie · doi:10.1007/s15034-025-5165-5
Fang, Q., Shi, J., Zhang, J., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23639884
Fang, Q., Shi, J., Zhang, J., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23639881
Fang, Q., Shi, J., Zhang, J., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23639878
Fang, Q., Shi, J., Zhang, J., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23639887
Verhulst, C. E. M., van Heck, J. I. P., Fabricius, T. W., Stienstra, R., Teerenstra, S., McCrimmon, R. J., Tack, C. J., Pedersen-Bjergaard, U., & de Galan, B. E. (2024) · Figshare · doi:10.6084/m9.figshare.25194822
Self-citationOxidative energy pathways in the human brain
Bose, A. (2024) · doi:10.5282/edoc.34262
Martinez-Alcala, M. F., Velez-Rangel, B. V., Lozano-Vazquez, C. F., & Ojeda, R. A. M. (2026) · Journal of Neonatal-Perinatal Medicine · doi:10.1177/19345798261424796
“This in-fl ammation can persist even after glucose normalization, and in genetically predisposed infants, may serve as a primer for long-term neurodevelopmental disruption 36 The kinetics of glycemic correction also have important implications.”
Rotbei, S., Soler, P. M., Barbancho, B. M., Lopez-Perez, L., Anchuelo, A. C., García, L. P., Forés, R. M., Matus, L. M., Albert, R. M., Andicoechea, A. O., et al. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03420-5 · Cited by 1
“Leukocytosis has demonstrated a strong correlation with the adrenaline response to hypoglycemia Ratter et al. [45].”
Injarabian, L. (2020) · theses.fr (ABES) · doi:10.70675/d505f876z0405z4419zbe01z07bf7a8dc156 · Cited by 1
Li, T., Li, C.-I., Liu, C.-S., Lin, C., Yang, S.-Y., & Lin, C. (2026) · Medicine · doi:10.1097/md.0000000000049991
“Several biological mechanisms have been proposed to explain the pathophysiological effects of hyper-glycemia on cardiovascular outcomes, including inflammatory cytokines, [3,4] oxidative stress, [5-8] and epigenetic changes.”
Akute diabetische Stoffwechselentgleisung
Mertens, M., Dauben, L., Roden, M., & Müssig, K. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2769-4961
“TNF-α und die Interleukine (IL-6, IL-8 und IL-1 β ) ausgeschüttet [11], die ebenso wie die Insulin-antagonistischen Hormone Kortisol, Wachstumshormon sowie Adrenalin und Nor-adrenalin zu einer peripheren Insulinresistenz führen, um die Bereitstellung der Glukose für das zentrale Nervensystem zu…”
Moin, A. S. M., Sathyapalan, T., Dempsey, L., Atkin, S. L., & Butler, A. E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.2016514
Metadata
- Authors
- Ratter, J. M., Rooijackers, H. M. M., Tack, C. J., Hijmans, A. G. M., Netea, M. G., de Galan, B. E., & Stienstra, R.
- Affiliations
- Radboud University Medical Center (NL)
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
- Corresponding author
- Ratter, Jacqueline M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-01-23
- Volume
- 66
- Issue
- 4
- Pages
- 1052-1061
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2580354129
- Cited by
- 94
- References
- 33
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 6 · 2021: 11 · 2020: 19 · 2019: 6 · 2018: 13 · 2017: 4
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Dutch Diabetes Research Foundation (DFN 2012.00.1542)
- European Foundation for the Study of Diabetes
- European Research Council Consolidator (310372)
- VIDI grant from the Netherlands Organisation for Scientific Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- hypoglycemia, type 1 diabetes, impaired awareness of hypoglycemia, inflammation, leukocytosis, peripheral blood mononuclear cells, monocytes, cytokine response, counterregulatory hormones, epinephrine, leukocyte mobilization, cardiovascular mortality
- MeSH terms
- Adult, Awareness, Diabetes Mellitus, Type 1, Epinephrine, Female, Glucose, Humans, Hypoglycemia, Leukocytosis, Lipopolysaccharides, Male, Monocytes, RNA, Messenger, Tumor Necrosis Factor-alpha, Glucose Clamp Technique, Gene Expression, Case-Control Studies, Cytokines, Chemokine CCL2, Lactic Acid, Interleukin-1beta, Young Adult, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.